中国医学装备
中國醫學裝備
중국의학장비
CHINA MEDICAL EQUIPMENT
2015年
6期
66-69,70
,共5页
梁颖%吴宁%耿建华%罗德红%方艳%郑容%张雯杰%刘瑛%李小萌
樑穎%吳寧%耿建華%囉德紅%方豔%鄭容%張雯傑%劉瑛%李小萌
량영%오저%경건화%라덕홍%방염%정용%장문걸%류영%리소맹
肿瘤残留或复发%鼻咽肿瘤%体层摄影术,正电子发射%氟脱氧葡萄糖%磁共振成像%纤维鼻咽镜检查
腫瘤殘留或複髮%鼻嚥腫瘤%體層攝影術,正電子髮射%氟脫氧葡萄糖%磁共振成像%纖維鼻嚥鏡檢查
종류잔류혹복발%비인종류%체층섭영술,정전자발사%불탈양포도당%자공진성상%섬유비인경검사
Neo plasmas residue or recurrence%Nasopharyngeal%Tomography,positron emission%Fluorodeoxyglucose%Magnetic resonance imaging%Naso phargo fiberscope
目的:探讨18F-FDG PET/CT在诊断鼻咽癌治疗后有无肿瘤残留或复发方面的应用价值。方法:55例鼻咽癌治疗结束后行18F-FDG PET/CT检查,其中38例纤维鼻咽镜(NPS)检查,31例磁共振成像(MRI)检查。以组织病理学或6个月以上临床和影像学随访结果作为诊断病灶性质的标准。计算PET/CT判断鼻咽局部肿瘤残留或复发的敏感性、特异性和准确性,并确定最大标准化摄取值(SUVmax)判断肿瘤残存或复发的界值。用ROC曲线分析比较PET/CT与NPS、MRI判断鼻咽局部肿瘤残留或复发的诊断效能。分析PET/CT对颈部淋巴结转移、远处转移以及第二原发癌的检出率。结果:PET/CT判断鼻咽局部肿瘤残留或复发的灵敏度、特异度和准确率分别为100%、87.9%和92.7%。SUVmax判断鼻咽局部肿瘤残留或复发的界值为4.2。PET/CT判断鼻咽局部肿瘤残留或复发的诊断准确率高于NPS(x2=7.11,P<0.05),与MRI相仿(x2=2.79,P>0.05)。PET/CT对颈部淋巴结转移的检出率为14.5%,远处转移检出率为10.9%,第二原发癌检出率为5.5%。结论:PET/CT不仅在判断鼻咽局部肿瘤残留或复发方面具有很高的准确性,而且PET/CT扫描有助于颈部淋巴结转移、远处转移和第二原发癌的检出,从而为鼻咽癌治疗后的再分期及治疗计划提供更全面的信息。
目的:探討18F-FDG PET/CT在診斷鼻嚥癌治療後有無腫瘤殘留或複髮方麵的應用價值。方法:55例鼻嚥癌治療結束後行18F-FDG PET/CT檢查,其中38例纖維鼻嚥鏡(NPS)檢查,31例磁共振成像(MRI)檢查。以組織病理學或6箇月以上臨床和影像學隨訪結果作為診斷病竈性質的標準。計算PET/CT判斷鼻嚥跼部腫瘤殘留或複髮的敏感性、特異性和準確性,併確定最大標準化攝取值(SUVmax)判斷腫瘤殘存或複髮的界值。用ROC麯線分析比較PET/CT與NPS、MRI判斷鼻嚥跼部腫瘤殘留或複髮的診斷效能。分析PET/CT對頸部淋巴結轉移、遠處轉移以及第二原髮癌的檢齣率。結果:PET/CT判斷鼻嚥跼部腫瘤殘留或複髮的靈敏度、特異度和準確率分彆為100%、87.9%和92.7%。SUVmax判斷鼻嚥跼部腫瘤殘留或複髮的界值為4.2。PET/CT判斷鼻嚥跼部腫瘤殘留或複髮的診斷準確率高于NPS(x2=7.11,P<0.05),與MRI相倣(x2=2.79,P>0.05)。PET/CT對頸部淋巴結轉移的檢齣率為14.5%,遠處轉移檢齣率為10.9%,第二原髮癌檢齣率為5.5%。結論:PET/CT不僅在判斷鼻嚥跼部腫瘤殘留或複髮方麵具有很高的準確性,而且PET/CT掃描有助于頸部淋巴結轉移、遠處轉移和第二原髮癌的檢齣,從而為鼻嚥癌治療後的再分期及治療計劃提供更全麵的信息。
목적:탐토18F-FDG PET/CT재진단비인암치료후유무종류잔류혹복발방면적응용개치。방법:55례비인암치료결속후행18F-FDG PET/CT검사,기중38례섬유비인경(NPS)검사,31례자공진성상(MRI)검사。이조직병이학혹6개월이상림상화영상학수방결과작위진단병조성질적표준。계산PET/CT판단비인국부종류잔류혹복발적민감성、특이성화준학성,병학정최대표준화섭취치(SUVmax)판단종류잔존혹복발적계치。용ROC곡선분석비교PET/CT여NPS、MRI판단비인국부종류잔류혹복발적진단효능。분석PET/CT대경부림파결전이、원처전이이급제이원발암적검출솔。결과:PET/CT판단비인국부종류잔류혹복발적령민도、특이도화준학솔분별위100%、87.9%화92.7%。SUVmax판단비인국부종류잔류혹복발적계치위4.2。PET/CT판단비인국부종류잔류혹복발적진단준학솔고우NPS(x2=7.11,P<0.05),여MRI상방(x2=2.79,P>0.05)。PET/CT대경부림파결전이적검출솔위14.5%,원처전이검출솔위10.9%,제이원발암검출솔위5.5%。결론:PET/CT불부재판단비인국부종류잔류혹복발방면구유흔고적준학성,이차PET/CT소묘유조우경부림파결전이、원처전이화제이원발암적검출,종이위비인암치료후적재분기급치료계화제공경전면적신식。
Objective:To investigate the diagnostic potential of 18F-FDG PET-CT for the detection of residual/recurrent nasopharyngeal carcinoma(NPC). Methods:Fifty-five NPC patients after therapy underwent follow-up with PET-CT. In 55 NPC, thirty-eight NPC patients were performed with both PET-CT and NPS, and thirty-one NPC patients with both PET-CT and MRI. The diagnosis standards were based on histopathological findings or clinical and imaging follow-up above 6 months. The sensitivity, specificity, and accuracy of PET-CT were analyzed, and an optimal cut-off of SUVmax was determined. PET-CT, NPS and MRI were compared for local residual or recurrent nasopharygeal carcinoma with receiver operating characteristic curves (ROC). The detection of neck lymph node metastasis, distant metastasis and second primary carcinoma were analyzed with PET-CT. Results:The sensitivity, specificity and accuracy of PET-CT were 100%, 87.9%, 92.7%for local residual/recurrent nasopharygeal carcinoma. The optimal cut-off of SUVmax was 4.2 for local tumor residual/recurrence. PET-CT showed better diagnostic accuracy than NPS(P<0.05), and similar accuracy to MRI (P>0.05). The detection of neck lymph node metastasis, distant metastasis and second primary carcinoma in NPC was 14.5%, 10.9%and 5.5%with PET-CT. Conclusion:PET-CT had a high accuracy of local residual/recurrent NPC at the primary tumor site and detection of neck lymph node metastasis, distant metastasis and second primary carcinomas. PET-CT would more comprehensive for tumor restaging and therapy strategy.